Related Experiment Videos
[Sympathetic ophthalmia versus Harada disease]
A Vanheesbeke1, F Rasquin, M Cordonnier
1Service d'Ophtalmologie, Hôpital Universitaire Erasme, U.L.B.
Bulletin De La Societe Belge D'Ophtalmologie
|January 1, 1996
Summary
Sympathetic ophthalmia, an immune condition, can cause severe eye inflammation and vision loss following injury. Early diagnosis and treatment, including corticosteroids or enucleation, are crucial for managing this rare but serious condition.
Area of Science:
- Ophthalmology
- Immunology
Background:
- Sympathetic ophthalmia is a rare, bilateral granulomatous panuveitis.
- It typically occurs after ocular trauma or surgery.
- Distinguishing it from other conditions like Harada disease is critical for appropriate management.
Observation:
- A patient presented with panuveitis and exudative retinal detachments in the right eye.
- This occurred months after an idiopathic corneal ulcer on the left eye.
Findings:
- Clinical and histological features suggested sympathetic ophthalmia.
- Harada disease was considered as a differential diagnosis due to similar presentations.
Implications:
- Corticosteroids are the primary treatment for sympathetic ophthalmia.
- Enucleation remains an option in severe or refractory cases.